The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of the Mars Shot Fund, an initiative to raise $100 million to help pay for research into nuclear medicine, molecular imaging, and therapy.

June 14, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced the creation of theMars Shot Fund, an initiative to raise $100 million to help pay for research intonuclear medicine,molecular imaging, and therapy. To date the fund has received $600,000 in grants and pledges, and work is underway to increase federal spending on this issue.

The Mars Shot initiative stemmed from an article published inThe Journal of Nuclear Medicine(JNM) which focused on the potential of innovation in the field. Current SNMMI president,Richard Wahl, MD, FACNM, wanted to further explore what the future of nuclear medicine could look like and, along with several colleagues, authored a paper forJNMthat detailed five areas for growth. These areas of focus included oncologic imaging, cardiac imaging, neurologic imaging, physics and data science, and radiopharmaceutical therapy.

沃尔说:“研究和开发对促进这五个增长领域至关重要,但目前缺乏资金。”“TheNational Institutes of Health(NIH), funding line is about 10 percent right now. The Mars Shot Fund is a way to help fund highly innovative, high impact research that might not be funded by NIH or other agencies.”

The Mars Shot Fund is led by a board of scientists and funders, as well as a Scientific Advisory Board which will guide the direction of the board in the science space. As additional funding is obtained, the board will make research money available through a grant application process. Applications will be reviewed by SNMMI study sections and, if approved, then awarded funding.

Individuals and organizations have already made generous donations to the Mars Shot Fund. The Lobular Breast Cancer Alliance has designated a $50,000 grant which will be matched by $50,000 from SNMMI. In addition, Scott and Carol Ann Smallwood—who tribute nuclear medicine with saving Scott’s life after being diagnosed with a neuroendocrine tumor—have pledged $500,000 over three years to the fund.

SNMMI is advising Congress to include a line item for the Mars Shot Fund in the Department of Energy or the Department of Defense budget in the coming session. Individuals are also being asked to contribute to the fund.

“We are in a revolutionary period for nuclear medicine, molecular imaging, and therapy,” said Wahl. “It’s essential that we capitalize on the momentum of this unparalleled innovation now so that we can continue to transform the nature of disease prevention, diagnosis, and treatment in the near future.”

If you would like to contribute to the Mars Shot Fund to support nuclear medicine and molecular imaging research, visitwww.snmmi.org/marsshot. Donations can be made directly to the fund or as part of the $50,000 challenge goal. These donations will be spendable dollars for immediate investment.

For more information:snmmi.org

Find more SNMMI22 coverage here


Related Content

News|Radiopharmaceuticals and Tracers

August 26, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

TimeAugust 25, 2022
arrow
Ms Preetha Reddy (Executive Vice Chairman AHEL), Dr Prathap Reddy (Chairman AHEL), Olivier Legrain (CEO IBA) & Dr Rakesh Jalali (Clinical Director APCC)
News|Proton Therapy

August 19, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...

TimeAugust 19, 2022
arrow
Mike Crosby
News|SNMMI

2022年8月16日——来自加利福尼亚州圣地亚哥的Mike Crosby被选为病人的副主席,任期两年。

TimeAugust 16, 2022
arrow
Feature|Magnetic Resonance Imaging (MRI)| Christine Book

August 10, 2022 — The imaging community has lost a legend, recognized for having revolutionized the field of diagnostic ...

TimeAugust 10, 2022
arrow
House-passed Appropriations Bills Include Key Measures to Improve Nuclear Medicine Patient Safety
News|Nuclear Imaging

July 27, 2022 — Patients for Safer Nuclear Medicine, a coalition of 29 patient advocacy organizations representing ...

TimeJuly 27, 2022
arrow
the findings could be used to inform the committee on BI-RADS regarding the possible incorporation of the MBI lexicon into the BI-RADS Atlas
News|2022世界杯篮球预选赛赛程

July 21, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), understanding the likelihood of malignancy ...

TimeJuly 22, 2022
arrow
NorthStar will provide Clovis with its environmentally preferred, high purity non-carrier-added (n.c.a.) Ac-225
News|Radiopharmaceuticals and Tracers

July 20, 2022 — -NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

TimeJuly 20, 2022
arrow
Radialis Inc. today announced that it has received clearance to market the Radialis PET Imager, an organ-targeted positron emission tomography (PET) system, in the United States
News|PET Imaging

July 19, 2022 — Radialis Inc. today announced that it has received clearance to market the Radialis PET Imager, an organ ...

TimeJuly 19, 2022
arrow
Iodixanol Injection, USP is the first U.S. FDA-approved generic iso-osmolar, dimeric iodinated contrast media agent, which is used during diagnostic x-ray-based imaging such as computed tomography (CT) scans
News|Contrast Media

July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the ...

TimeJuly 18, 2022
arrow
The global molecular imaging market is estimated to be USD 6,750.1 million in 2021 and is expected to witness a CAGR of 7.84% during the forecast period
News|Molecular Imaging

July 11, 2022 — The "Molecular Imaging Market, by Application (Cancer, Heart Disease, Brain Disorder), by Technology ...

TimeJuly 12, 2022
arrow
Subscribe Now